LBCA’s Lead Research Advocate and Publications/Clinical Trials Curator, Patient Advocate Advisory Board member and founding member of the Alliance, Julia Levine, recently interviewed our new Scientific Advisory […]
Interview with New SAB Board Member, Dr. Rebecca Shatsky Read More »
In July 2022, I received a job offer in my hometown of San Antonio, TX. I had been in Dallas for 20 years and loved
My ILC Story – Kim Shares Her Story with Lobular Breast Cancer Read More »
Many individuals with lobular breast cancer have found LBCA after they were diagnosed. They want to help build a community among peers, to share the
My ILC Story – Judith Shares Her Story with Lobular Breast Cancer Read More »
Over the past nearly four years I have learned a lot about the various forms that advocacy and volunteerism can take, especially at a small
LBCA’s Volunteers Are Changing the World For Others with Lobular Breast Cancer! Read More »
Many individuals with lobular breast cancer have found LBCA after they were diagnosed. They want to help build a community among peers, to share the
My ILC Story – Harvey Read More »
LBCA: Tell us a little about your expertise, your ILC research, yourself, and why you think it is important to focus on lobular research? Dr.
Q&A with SAB Member Dr. Fresia Pareja Read More »
Many women with lobular breast cancer have found LBCA after they were diagnosed. They want to help build a community among peers, to share the
My ILC Story – Leslie Read More »
The 2023 San Antonio Breast Cancer Symposium (SABCS22) included 20 research posters focused on lobular breast cancer. Posters at research conferences are tools used to
A Collection of ILC Focused Poster Summaries from SABCS23 Read More »
Many women with lobular breast cancer have found LBCA after they were diagnosed. They want to help build a community among peers, to share the
My ILC Story – Lucy Read More »
LBCA has made significant progress related to our 5 strategic goals this first half of FY24. The following is a review of some of our
LBCA’s Progress on Strategic Goals During First Half FY24 Read More »
Name/Description of Trial: GALILEE: Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT / NCT05931302 Summary: Lobular breast cancer
On Halloween, during October Breast Cancer Awareness Month, LBCA staff Laurie Hutcheson and Mason Mitchell-Daniels and patient advocate volunteer Beth Davis had the opportunity to visit
Seeing Lobular Breast Cancer Research Up Close in the Lab Read More »
Invasive Lobular Carcinoma finally merited a full session at the world’s largest breast cancer conference, the San Antonio Breast Cancer Symposium. LBCA proudly sponsored this
Lobular Breast Cancer had New Prominence at SABCS 2023 Read More »
Many women with lobular breast cancer have found LBCA after they were diagnosed. They want to help build a community among peers, to share the
My ILC Story – Beth Read More »
Lobular Breast Cancer Alliance Inc. (LBCA) is a Delaware nonprofit corporation that is registered as a 501(c)(3) public charity. Tax ID Number: 86-2260246. Donations to LBCA are tax-deductible. to the fullest extent allowed by applicable law.
© 2024 The Lobular Breast Cancer Alliance Inc. | Privacy Policy | Terms of Use | State Fundraising Notices
Site by SuzanneHarrisonWeb.com
Notifications